These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 31434273)

  • 1. Advances in Biodegradable Nano-Sized Polymer-Based Ocular Drug Delivery.
    Lynch C; Kondiah PPD; Choonara YE; du Toit LC; Ally N; Pillay V
    Polymers (Basel); 2019 Aug; 11(8):. PubMed ID: 31434273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breaking Barriers in Eye Treatment: Polymeric Nano-Based Drug-Delivery System for Anterior Segment Diseases and Glaucoma.
    Wu KY; Ashkar S; Jain S; Marchand M; Tran SD
    Polymers (Basel); 2023 Mar; 15(6):. PubMed ID: 36987154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.
    Onugwu AL; Nwagwu CS; Onugwu OS; Echezona AC; Agbo CP; Ihim SA; Emeh P; Nnamani PO; Attama AA; Khutoryanskiy VV
    J Control Release; 2023 Feb; 354():465-488. PubMed ID: 36642250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases.
    Tsung TH; Tsai YC; Lee HP; Chen YH; Lu DW
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems.
    Wu KY; Joly-Chevrier M; Akbar D; Tran SD
    Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development, Optimization, and Clinical Relevance of Lactoferrin Delivery Systems: A Focus on Ocular Delivery.
    Ponzini E; Astolfi G; Grandori R; Tavazzi S; Versura P
    Pharmaceutics; 2024 Jun; 16(6):. PubMed ID: 38931931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in topical nano drug-delivery systems for the anterior ocular segment.
    Lakhani P; Patil A; Majumdar S
    Ther Deliv; 2018 Feb; 9(2):137-153. PubMed ID: 29325511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application.
    Tsai CH; Wang PY; Lin IC; Huang H; Liu GS; Tseng CL
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular drug delivery to the anterior segment using nanocarriers: A mucoadhesive/mucopenetrative perspective.
    Dave RS; Goostrey TC; Ziolkowska M; Czerny-Holownia S; Hoare T; Sheardown H
    J Control Release; 2021 Aug; 336():71-88. PubMed ID: 34119558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-based eye drop: Topical and noninvasive therapy for ocular diseases.
    Wang C; Pang Y
    Adv Drug Deliv Rev; 2023 Mar; 194():114721. PubMed ID: 36773886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural biodegradable polymers based nano-formulations for drug delivery: A review.
    George A; Shah PA; Shrivastav PS
    Int J Pharm; 2019 Apr; 561():244-264. PubMed ID: 30851391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of lipid nanoparticles to ocular drug delivery.
    Battaglia L; Serpe L; Foglietta F; Muntoni E; Gallarate M; Del Pozo Rodriguez A; Solinis MA
    Expert Opin Drug Deliv; 2016 Dec; 13(12):1743-1757. PubMed ID: 27291069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances.
    Wang R; Gao Y; Liu A; Zhai G
    J Drug Target; 2021 Aug; 29(7):687-702. PubMed ID: 33474998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colloidal nanosystems with mucoadhesive properties designed for ocular topical delivery.
    Silva B; São Braz B; Delgado E; Gonçalves L
    Int J Pharm; 2021 Sep; 606():120873. PubMed ID: 34246741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Niosomal Drug Delivery Systems for Ocular Disease-Recent Advances and Future Prospects.
    Durak S; Esmaeili Rad M; Alp Yetisgin A; Eda Sutova H; Kutlu O; Cetinel S; Zarrabi A
    Nanomaterials (Basel); 2020 Jun; 10(6):. PubMed ID: 32570885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic nanoemulsions in ophthalmic drug administration: Concept in formulations and characterization techniques for ocular drug delivery.
    Singh M; Bharadwaj S; Lee KE; Kang SG
    J Control Release; 2020 Dec; 328():895-916. PubMed ID: 33069743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocrystal for ocular drug delivery: hope or hype.
    Sharma OP; Patel V; Mehta T
    Drug Deliv Transl Res; 2016 Aug; 6(4):399-413. PubMed ID: 27165145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomaterial-based ophthalmic drug delivery.
    Xie G; Lin S; Wu F; Liu J
    Adv Drug Deliv Rev; 2023 Sep; 200():115004. PubMed ID: 37433372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical, biomedical and ophthalmic applications of biodegradable polymers (BDPs): literature and patent review.
    Osi B; Khoder M; Al-Kinani AA; Alany RG
    Pharm Dev Technol; 2022 Mar; 27(3):341-356. PubMed ID: 35297285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.